Paper Details

  1. Home
  2. Paper Details

[Cutaneous side effects induced by D-penicillamine in the treatment of rheumatoid arthritis].

Author: BaratelliE, BrogginiM, CappelliA, CrespiE, FilardiP G, VolontèS

English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

D-penicillamine is a drug used for rheumatoid arthritis that can cause skin side effects, including rashes and drug-induced pemphigus. The drug needs to be discontinued if these reactions occur.
Paper Details　
Original Abstract of the Article :
After considering the cutaneous side effects of D-penicillamine in rheumatoid arthritis management, a few cases of cutaneous adverse reaction observed in 5 (13%) of 38 patients, who received the drugs, are described. Two patients had an early rash; one showed a late rash; one had a late rash with sy...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/2138721

データ提供：米国国立医学図書館（NLM）

D-Penicillamine: A Double-Edged Sword in Rheumatoid Arthritis Treatment

This study explores the cutaneous side effects of D-penicillamine, a medication used to treat rheumatoid arthritis. The authors describe several cases of cutaneous adverse reactions observed in patients receiving the drug, highlighting the potential risks associated with this treatment. The study emphasizes the need for careful monitoring and prompt intervention to manage these side effects.

Balancing Benefits and Risks: Navigating D-Penicillamine Therapy

The study highlights the potential for serious cutaneous side effects, including rashes, pemphigus, and drug-induced lupus erythematosus (LES). The authors emphasize the importance of early detection and discontinuation of D-penicillamine therapy in cases of severe adverse reactions. The study underscores the need for a careful balance between the benefits and risks associated with this medication.

A Camel's Perspective: The Journey of Rheumatoid Arthritis Treatment

Like a camel navigating a treacherous desert, patients with rheumatoid arthritis often face a challenging journey of treatment. This study reminds us that even effective medications can have unintended consequences. It highlights the importance of open communication between patients and healthcare professionals to ensure optimal care and minimize potential risks.

Dr.Camel's Conclusion

This research highlights the potential for serious cutaneous side effects associated with D-penicillamine therapy. Careful monitoring and prompt intervention are crucial for managing these risks and ensuring the safety of patients receiving this medication.

Date :
  1. Date Completed 1990-05-10
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

2138721

DOI: Digital Object Identifier

2138721

SNS
PICO Info
in preparation
Languages

Italian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.